Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for SARACATINIB ZUR VERWENDUNG BEI DER BEHANDLUNG VON IDIOPATHISCHER LUNGENFIBROSE
Details for 2020710607
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2020710607
Title / Product Name
SARACATINIB ZUR VERWENDUNG BEI DER BEHANDLUNG VON IDIOPATHISCHER LUNGENFIBROSE
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2020710607
EP Publication Number
3930715
E-Number
1684445
Language
EN
PCT Number
IB20051642
Publication Date
05.01.2022 A
08.05.2024 B1
Registration Date
08.05.2024
AT Publication Date
15.05.2024
Application Date
26.02.2020
Registration Number
-
Priorities
27.02.2019
US
201962811009 P
IPC
A61K 31/4412 20060101AFI20200904BHEP
Maximum Duration of Protection
26.02.2040
Owner
Astrazeneca AB
151 85 Södertälje
SE
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Hansastr. 27c
80686 München
DE
Representative
No representatives present
Inventor
COUSENS, Leslie
AstraZeneca Pharmaceuticals LP 35 Gatehouse Drive
Waltham, Massachusetts 02451
US
NIVENS, Chad
AstraZeneca Pharmaceuticals LP 35 Gatehouse Drive
Waltham, Massachusetts 02451
US
ESCOTT, Katherine Jane
AstraZeneca UK Limited 1 Francis Crick Avenue Cambridge Biomedical Campus
Cambridge CB2 0AA
GB
MONKLEY, Susan
AstraZeneca AB Pepparedsleden 1
Mölndal
SE
PRASSE, Antje
Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V. Hansastraße 27c
München
DE
Information about Fees
Click here to load the fees